Harrow Shares Fall 25% After 3Q Results Miss Estimates

Dow Jones

Nov 14, 2024

By Kailyn Rhone

Shares of Harrow slipped after the pharmaceutical company reported third-quarter results that missed analysts' expectations.

The stock closed down 25%, at $39.10, in after-hours trading Wednesday. For the year, shares are up 362%.

The Nashville company reported a third-quarter loss of $4.2 million, or 12 cents a share, compared with a loss of $4.4 million, or 13 cents a share, for the same period a year earlier. Analysts polled by FactSet expected a loss of five cents.

Revenue rose 44%, to $49.3 million. That fell short of the $52.8 million expected by analysts polled by FactSet.

Chief Executive Mark L. Baum said the company sees strong performance for the fourth quarter and expects "a record-breaking finish" for the year.

Write to Kailyn Rhone at kailyn.rhone@wsj.com

(END) Dow Jones Newswires

November 13, 2024 17:37 ET (22:37 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2483869524"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483869524\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2483869524?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-14 06:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483869524","market":"sg","top_or_hot":-1,"title":"Harrow Shares Fall 25% After 3Q Results Miss Estimates","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Kailyn Rhone \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Harrow slipped after the pharmaceutical company reported third-quarter results that missed analysts' expectations. \n</p>\n<p>\n  The stock closed down 25%, at $39.10, in after-hours trading Wednesday. For the year, shares are up 362%. \n</p>\n<p>\n  The Nashville company reported a third-quarter loss of $4.2 million, or 12 cents a share, compared with a loss of $4.4 million, or 13 cents a share, for the same period a year earlier. Analysts polled by FactSet expected a loss of five cents. \n</p>\n<p>\n  Revenue rose 44%, to $49.3 million. That fell short of the $52.8 million expected by analysts polled by FactSet. \n</p>\n<p>\n  Chief Executive Mark L. Baum said the company sees strong performance for the fourth quarter and expects \"a record-breaking finish\" for the year. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 13, 2024 17:37 ET (22:37 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Harrow Shares Fall 25% After 3Q Results Miss Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHarrow Shares Fall 25% After 3Q Results Miss Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-11-14 06:37</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Kailyn Rhone \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Harrow slipped after the pharmaceutical company reported third-quarter results that missed analysts' expectations. \n</p>\n<p>\n  The stock closed down 25%, at $39.10, in after-hours trading Wednesday. For the year, shares are up 362%. \n</p>\n<p>\n  The Nashville company reported a third-quarter loss of $4.2 million, or 12 cents a share, compared with a loss of $4.4 million, or 13 cents a share, for the same period a year earlier. Analysts polled by FactSet expected a loss of five cents. \n</p>\n<p>\n  Revenue rose 44%, to $49.3 million. That fell short of the $52.8 million expected by analysts polled by FactSet. \n</p>\n<p>\n  Chief Executive Mark L. Baum said the company sees strong performance for the fourth quarter and expects \"a record-breaking finish\" for the year. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 13, 2024 17:37 ET (22:37 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4557","symbol_name":"大麻股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2483869524","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483869524","pubTimestamp":1731537420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Harrow slipped after the pharmaceutical company reported third-quarter results that missed analysts' expectations.The stock closed down 25%, at $39.10, in after-hours trading Wednesday. For the year, shares are up 362%.The Nashville company reported a third-quarter loss of $4.2 million, or 12 cents a share, compared with a loss of $4.4 million, or 13 cents a share, for the same period a year earlier. Analysts polled by FactSet expected a loss of five cents.Revenue rose 44%, to $49.3 million. That fell short of the $52.8 million expected by analysts polled by FactSet.Chief Executive Mark L. Baum said the company sees strong performance for the fourth quarter and expects \"a record-breaking finish\" for the year.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4557":"大麻股","HROW":"Harrow Health Inc","BK4007":"制药"},"translate_title":"第三季度业绩未达预期，哈罗股价下跌25%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HROW":0.9},"content_text":"By Kailyn Rhone \n\n\n \n\n\n  Shares of Harrow slipped after the pharmaceutical company reported third-quarter results that missed analysts' expectations. \n\n\n  The stock closed down 25%, at $39.10, in after-hours trading Wednesday. For the year, shares are up 362%. \n\n\n  The Nashville company reported a third-quarter loss of $4.2 million, or 12 cents a share, compared with a loss of $4.4 million, or 13 cents a share, for the same period a year earlier. Analysts polled by FactSet expected a loss of five cents. \n\n\n  Revenue rose 44%, to $49.3 million. That fell short of the $52.8 million expected by analysts polled by FactSet. \n\n\n  Chief Executive Mark L. Baum said the company sees strong performance for the fourth quarter and expects \"a record-breaking finish\" for the year. \n\n\n \n\n\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 17:37 ET (22:37 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}